Abstract
Renal artery stenosis as defined by narrowing of one or more of the renal arteries by more than 50%, can cause significant morbidity and mortality in those patients predisposed to atherosclerotic disease. Clinical manifestations include recurrent pulmonary edema, unstable angina, renovascular hypertension, and ischemic nephropathy, which are associated with worse patient outcomes. While non-invasive methods such as duplex ultrasound and computed tomography can diagnose renal artery stenosis, invasive angiography remains the gold standard. Medical therapy is sufficient in a majority of patients; however a small subset of patients will benefit from an invasive approach. We will review the data underlying decision making strategies in this high risk patient cohort.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Parikh SA, Shishehbor MH, Gray BH, White CJ, Jaff MR. SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv. 2014;84(7):1163–71.
Kalra PA, Guo H, Kausz AT, et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005;68:293–301.
Hansen KJ, Edwards MS, Craven TE, et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36:443–51.
Olin JW, Melia M, Young JR, et al. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med. 1990;88:46N–51N.
Derkx FH, Schalekamp MA. Renal artery stenosis and hypertension. Lancet. 1994;344(8917):237–9.
Rokni N, Salarifar M, Hakki Kazazi E, Goodarzynejad H. Frequency and predictors of renal artery stenosis in patients undergoing simultaneous coronary and renal catheterization. J Tehran Heart Cent. 2012;7(2):58–64.
Goldblatt H, Lynch J, Hanzal RF, Summerville WW. Studies on experimental hypertension, I: the production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 1934;59:347–79.
Taquini AC Jr, Taquini AC. The renin-angiotensin system in hypertension. Am Heart J. 1961;62:558–64.
Li J, Parikh SA. Management of renal arterial disease. Interv Cardiol Clin. 2014;3(4):501–16.
Gloviczki ML, Glockner JF, Lerman LO, McKusick MA, Misra S, Grande JP, Textor SC. Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension. 2010;55(4):961–6.
Rihal CS, Textor SC, Breen JF, et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc. 2002;77:309–16.
Parikh SA, Shishehbor MH, Gray BH, White CJ, Jaff MR. SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv. 2014;84(7):1163–71.
Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. 2004;350(18):1862–71.
Kadian-Dodov D, Gornik HL, Gu X, Froehlich J, Bacharach JM, Chi YW, Gray BH, Jaff MR, Kim ES, Mace P, Sharma A, Kline-Rogers E, White C, Olin JW. Dissection and aneurysm in patients with fibromuscular dysplasia: findings from the U.S. registry for FMD. J Am Coll Cardiol. 2016;68(2):176–85.
Granata A, Fiorini F, Andrulli S, Logias F, Gallieni M, Romano G, Sicurezza E, Fiore CE. Doppler ultrasound and renal artery stenosis: an overview. J Ultrasound. 2009;12(4):133–43.
Olbricht CJ, Paul K, Prokop M, Chavan A, Schaefer-Prokop CM, Jandeleit K, Koch KM, Galanski M. Minimally invasive diagnosis of renal artery stenosis by spiral computed tomography angiography. Kidney Int. 1995;48(4):1332–7.
Kim TS, Chung JW, Park JH, Kim SH, Yeon KM, Han MC. Renal artery evaluation: comparison of spiral CT angiography to intra-arterial DSA. J Vasc Interv Radiol. 1998;9(4):553–9.
Hertz SM, Holland GA, Baum RA, Haskal ZJ, Carpenter JP. Evaluation of renal artery stenosis by magnetic resonance angiography. Am J Surg. 1994;168(2):140–3.
Gedroyc WM, Neerhut P, Negus R, Palmer A, al Kutoubi A, Taube D, Hulme B. Magnetic resonance angiography of renal artery stenosis. Clin Radiol. 1995;50(7):436–9.
De Bruyne B, Manoharan G, Pijls NH, et al. Assessment of re-nal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol. 2006;48:1851–1855.14.
Leesar MA, Varma J, Shapira A, et al. Prediction of hypertension improvement after stenting of renal artery stenosis:comparative accuracy of translesional pressure gradients, intra-vascular ultrasound, and angiography. J Am Coll Cardiol. 2009;53:2363–71.
Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss L, Golzarian J, Gornik HL, Jaff MR, Moneta GL, Olin JW, Stanley JC, White CJ, White JV, Zierler RE, American College of Cardiology Foundation Task Force; American Heart Association Task Force. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(14):1555–70.
Modrall JG, Rosero EB, Smith ST, et al. Operative mortality for renal artery bypass in the United States: results from the National Inpatient Sample. J Vasc Surg. 2008;48(2):317–22.
Liang P, Hurks R, Bensley RP, Hamdan A, Wyers M, Chaikof E, Schermerhorn ML. The rise and fall of renal artery angioplasty and stenting in the United States, 1988-2009. J Vasc Surg. 2013;58(5):1331–8.
Trani C, Tommasino A, Burzotta F. Transradial renal stenting: why and how. Catheter Cardiovasc Interv. 2009;74(6):951–6.
Allie DE, Lirtzman MD, Wyatt CH, Keller VA, Khan MH, Khan MA, Fail PS, Hebert CJ, Ellis SD, Mitran E, Chaisson G, Stagg S Jr, Allie AA, Walker CM. Bivalirudin as a foundation anticoagulant in peripheral vascular disease: a safe and feasible alternative for renal and iliac interventions. J Invasive Cardiol. 2003;15(6):334–42.
Feldman RL, Wargovich TJ, Bittl JA. No-touch technique for reducing aortic wall trauma during renal artery stenting. Catheter Cardiovasc Interv. 1999;46(2):245–8.
White CJ. Optimizing outcomes for renal artery intervention. Circ Cardiovasc Interv. 2010;3(2):184–92.
Jaff MR, Bates M, Sullivan T, Popma J, Gao X, Zaugg M, Verta P, HERCULES Investigators. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial. Catheter Cardiovasc Interv. 2012;80(3):343–50.
Bersin RM, Ansel G, Rizzo A, Bob Smouse H, Sinha S, Sachar R, Dave R, Weinstock BS, Feldman R, Roubin GS. Nine-month results of the REFORM study: a prospective, single-arm, multicenter clinical study of the safety and effectiveness of the Formula™ balloon-expandable stent for treatment of renal artery stenosis. Catheter Cardiovasc Interv. 2013;82(2):266–73.
Cooper CJ, Haller ST, Colyer W, et al. Embolic protection and platelet inhibition during renal artery stenting. Circulation. 2008;117(21):2752–60.
Rocha-Singh K, Jaff MR, Lynne Kelley E, et al. Renal artery stenting with noninvasive duplex ultrasound follow-up: 3-year results from the RENAISSANCE renal stent trial. Catheter Cardiovasc Interv. 2008;72(6):853–62.
Weinberg I, Keyes MJ, Giri J, et al. Blood pressure response to renal artery stenting in 901 patients from five prospective multicenter FDA-approved trials. Catheter Cardiovasc Interv. 2014;83(4):603–9.
Laird JR, Rundback J, Zierler RE, et al. Safety and efficacy of renal artery stenting following suboptimal renal angioplasty for de novo and restenotic ostial lesions: results from a nonrandomized, prospective multicenter registry. J Vasc Interv Radiol. 2010;21(5):627–37.
Rocha-Singh K, Jaff MR, Rosenfield K, et al. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol. 2005;46(5):776–83.
Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998;31:823–9.
van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch renal artery stenosis intervention cooperative study group. N Engl J Med. 2000;342:1007–14.
ASTRAL Investigators, Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953–62.
Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, et al. Stenting and medical therapy for atherosclerotic renal artery stenosis. N Engl J Med. 2014;370:13–22.
Zeller T, Rastan A, Schwarzwalder U, et al. Treatment of in-stent restenosis following stent-supported renal artery angioplasty. Catheter Cardiovasc Interv. 2007;70(3):454–9.
Conlon PJ, Little MA, Pieper K, Mark DB. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001;60(4):1490–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sethi, S.S., Parikh, S.A. (2020). Renal Artery Stenosis: State of the Art in the Diagnosis and Management. In: Rangaswami, J., Lerma, E., McCullough, P. (eds) Kidney Disease in the Cardiac Catheterization Laboratory . Springer, Cham. https://doi.org/10.1007/978-3-030-45414-2_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-45414-2_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-45413-5
Online ISBN: 978-3-030-45414-2
eBook Packages: MedicineMedicine (R0)